首页> 美国卫生研究院文献>International Journal of Nanomedicine >Synthesis characterization and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products
【2h】

Synthesis characterization and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products

机译:抗菌氯己定六偏磷酸盐纳米颗粒的合成表征和功效用于生物医学材料和消费品

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chlorhexidine (CHX) is an antimicrobial agent that is efficacious against gram-negative and -positive bacteria and yeasts. Its mechanism of action is based on cell membrane disruption and, as such, it does not promote the development of bacterial resistance, which is associated with the widespread use of antibiotics. In this manuscript, we report the development of novel antimicrobial nanoparticles (NPs) based on a hexametaphosphate salt of CHX. These are synthesized by instantaneous reaction between equimolar aqueous solutions of CHX digluconate and sodium hexametaphosphate, under room temperature and pressure. The reaction results in a stable colloid composed of highly negatively charged NPs (−50 mV), of size 20–160 nm. The NPs adhere rapidly to specimens of glass, titanium, and an elastomeric wound dressing, in a dose-dependent manner. The functionalized materials exhibit a gradual leaching of soluble CHX over a period of at least 50 days. The NP colloid is efficacious against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in both planktonic and biofilm conditions. These NPs may find application in a range of biomedical and consumer materials.
机译:洗必泰(CHX)是一种抗革兰氏阴性和阳性细菌和酵母菌的抗菌剂。它的作用机理是基于细胞膜破坏,因此,它不会促进细菌耐药性的发展,这与抗生素的广泛使用有关。在此手稿中,我们报告了基于CHX六偏磷酸盐的新型抗菌纳米颗粒(NP)的开发。这些是通过在室温和压力下,CHX二葡萄糖酸酯的等摩尔水溶液与六偏磷酸钠之间的瞬时反应合成的。反应产生稳定的胶体,该胶体由高度带负电荷的NP(−50 mV)组成,大小为20–160 nm。 NP以剂量依赖的方式迅速粘附在玻璃,钛和弹性伤口敷料的标本上。功能化材料在至少50天的时间内显示出可溶性CHX的逐渐浸出。 NP胶体在浮游生物膜和生物膜条件下均能有效抵抗耐甲氧西林的金黄色葡萄球菌(MRSA)和铜绿假单胞菌。这些NP可在一系列生物医学和消费材料中找到应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号